Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0600

+16.5%

3:10 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mammon who wrote (11434)	7/12/2012 10:33:40 AM
From: NTTG	1 Recommendation Read Replies (1) of 13111

Ummm...2009 was the year they announced PIII results for their new Lupus drug, and they submitted a BLA for their inhaled anthrax therapy, and they started their PIII for Hep C, and they had candidate drugs in PIII for diabetes and cardiovascular disease, and they had a PII for cancer media.corporate-ir.net The decline in SP during 2011 and 2012 seems to reflect some stalled progress in developing the rest of their pipeline.... phx.corporate-ir.net I can sees how their stalled progress would be an interesting comparison to PVCT, but I don't get the suggestion of a 2009 performance comparison....where do you see similar depth and breadth of R&D from PVCT?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next